Page last updated: 2024-10-30

metformin and Laron Syndrome

metformin has been researched along with Laron Syndrome in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Laron Syndrome: An autosomal recessive disorder characterized by short stature, defective GROWTH HORMONE RECEPTOR, and failure to generate INSULIN-LIKE GROWTH FACTOR I by GROWTH HORMONE. Laron syndrome is not a form of primary pituitary dwarfism (GROWTH HORMONE DEFICIENCY DWARFISM) but the result of mutation of the human GHR gene on chromosome 5.

Research Excerpts

ExcerptRelevanceReference
"His parents both had a diagnosis of type 2 diabetes."1.39Diabetes mellitus with Laron syndrome: case report. ( Agladıoglu, SY; Aycan, Z; Bas, VN; Cetınkaya, S; Kendırcı, HN; Onder, A; Savas Erdeve, S, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agladıoglu, SY1
Cetınkaya, S1
Savas Erdeve, S1
Onder, A1
Kendırcı, HN1
Bas, VN1
Aycan, Z1

Other Studies

1 other study available for metformin and Laron Syndrome

ArticleYear
Diabetes mellitus with Laron syndrome: case report.
    Journal of pediatric endocrinology & metabolism : JPEM, 2013, Volume: 26, Issue:9-10

    Topics: Adult; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Monitoring; Humans; Hypoglycemic Agen

2013